NVIDIA NIMs for Drug Discovery and Robotics Pipelines on SageMaker
Action Required
Organizations can now deploy and scale AI-powered drug discovery and robotics pipelines more efficiently using NVIDIA's optimized models on AWS.
AI Impact Summary
NVIDIA is expanding its NIMs (Neural Intervention Models) for drug discovery and robotics pipelines to run on SageMaker JumpStart. This capability allows users to leverage NVIDIA's optimized models for production-ready AI workloads directly within the AWS ecosystem, simplifying deployment and scaling for applications in biosciences and robotics. This expansion represents a significant investment in NVIDIA's ecosystem and provides a streamlined path for customers to accelerate their AI-driven research and development efforts.
Affected Systems
- Date
- Date not specified
- Change type
- capability
- Severity
- high